The effect of SNCA 3' region on the levels of SNCA-112 splicing variant. - Wikidata - awgldk - TriplyDB

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

http://www.wikidata.org/entity/Q34538444

about

α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease The chaperone-like activity of α-synuclein attenuates aggregation of its alternatively spliced isoform, 112-synuclein in vitro: plausible cross-talk between isoforms in protein aggregation.Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.Head injury, α-synuclein genetic variability and Parkinson's disease.Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain.Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.Splicing: is there an alternative contribution to Parkinson's disease?Reduced expression of α-synuclein in alcoholic brain: influence of SNCA-Rep1 genotype.Up-regulation of SNCA gene expression: implications to synucleinopathies Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity Genetic variability in SNCA and Parkinson's disease.α-Synuclein in Parkinson's disease.α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.Aberrant alternative splicing events in Parkinson's disease.Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury.Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168.Inclusion of a portion of the native SNCA 3'UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra.SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases.Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.

P2860

Q21090919-A5695CA6-7F63-4AF2-92DB-7B8F7FD6E16E Q33707184-511B92BE-B16E-415C-95C7-684467B334BB Q33813336-20798D3B-9B61-4280-8B3C-2C3705523871 Q33906476-E08163E0-E24B-483D-9685-00CB7B269468 Q35327353-8A1B3109-0BD6-47EC-A8AB-FC303DC70940 Q35864260-81768766-E03C-486C-BCCB-92DF78679A73 Q35924447-8F65191E-32E9-4A30-9A98-5A0F3C59CA7D Q36069844-96FDFF72-8874-4634-AB54-FD2DEFD7953E Q36527631-E60F9639-8660-4745-9043-1B04EE554F44 Q37004246-252E2282-90EC-4BB2-BD09-798F405333C9 Q37572904-64BDDBC0-B483-490D-A849-5EB43949A9B5 Q37612718-96D78A1C-4131-4A31-8113-EFA363BBFD93 Q37907930-D5E8B7EB-6204-4B13-8419-0371E4D1A766 Q37987146-0FE1F398-4328-4ECF-8CFF-CFEBD94B03F1 Q38038123-B99E4E2C-A466-4028-866B-0E456406140E Q38057874-8A440850-97D1-4773-AABA-7543C743FB5A Q38637878-E697D14E-29CA-41DF-82B3-BCCCCF8995B5 Q38837331-252452EB-20AC-4073-8B64-26A6B70087B9 Q39264615-EAD7145D-7019-4F51-B500-23002009D4DA Q39687917-7167B333-198B-41F3-9B13-2C6A41BCFA32 Q40961889-D14ABC08-CD90-4DF7-8C31-F15CB7DA71C1 Q41846096-3D1C805E-BABC-402D-88B8-473E6779491A Q42179493-B0691C27-81AE-4A1C-BF59-A2A9AADA3571 Q43521013-1A511ED4-24A9-48A1-B243-E22785EE2946 Q44603447-F7D46C73-BAF6-4CBF-B1C0-3F42F4EFBBD0 Q47839926-3CCEAE91-C526-4DFC-B00E-BE50C1FE9529 Q52568381-04971A54-3341-4B7C-9FD6-F841470FF661

P2860

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

http://www.wikidata.org/entity/Q34538444

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@ast

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@en

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@nl

type

label

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@ast

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@en

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@nl

prefLabel

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@ast

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@en

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@nl

P1433

Q34538444-7617D28A-83B2-4C80-8344-EA691AEAEB4A

P1476

Q34538444-0335B4DD-9A4A-4D36-9AE7-9456A6C2954C

P2093

Q34538444-300A5E37-B2C3-4F8E-80C3-6BA6517FBA97

Q34538444-3658F2BC-3279-4523-A246-7229C7C20F46

Q34538444-369A666A-989A-4BFD-8035-17DA3E90328D

Q34538444-75AF46BD-178F-4393-8962-799E8AFDC94F

Q34538444-8D3DF05C-A1DF-4671-8451-15D4D3B57737

Q34538444-F4DBEEF5-2842-49CA-AAE8-F04D09286CE0

P2860

Q34538444-3480CE8E-FB7F-4CFE-BA34-3FC33DFD3888

Q34538444-35130C79-BE63-4876-B7BA-62E5D769020C

Q34538444-3B48807F-794A-4F04-96E8-5B2AFB23FD84

Q34538444-439B2B83-427A-4BC3-88A2-05B21FC8D38A

Q34538444-4B875346-41DB-476C-9536-9B17CC571C38

Q34538444-558CF93A-CB0F-4FCE-8379-393E6B41B61A

Q34538444-5869446D-4583-4B6C-8A00-00F4CA776773

Q34538444-5CD07BAE-5DA6-4658-9B67-366480A5E1F3

Q34538444-600E938D-F4BC-4759-8649-7C3B1678FB19

Q34538444-648CF6FB-AB34-44EA-A199-13E5DAB5B1C8

P2888

Q34538444-25ADC702-BDA2-4584-AC88-CB1061AE7C96

P304

Q34538444-E3D9B94D-125E-47F8-ACA7-87E430A7D840

P31

Q34538444-5EBE0F49-F79A-4D7A-8E7C-D383BE8B76BD

P356

Q34538444-044A923E-E1E9-40DE-80B7-F5B21CDFAE5E

P433

Q34538444-C866C81D-5E84-4916-8630-D3A03D122E69

P478

Q34538444-74CF2224-AC9C-4CDC-A579-7C86F0C6665E

P50

Q34538444-045BA621-6894-4479-817F-5FE333AD5694

P577

Q34538444-50815168-951B-4914-8DDC-6D5DA1DD9998

P5875

Q34538444-3A718D8F-A868-45BD-9E42-8345B3BABCE4

P698

Q34538444-258B9EF9-E02F-4230-A30C-EE92EE420EE5

P932

Q34538444-3E2E982B-F409-4103-9D5C-01076F457755

P356

S10048-010-0263-4

P1433

P1476

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

@en

P2093

Christine M Hulette

http://www.w3.org/2001/XMLSchema#string

Colton Linnertz

http://www.w3.org/2001/XMLSchema#string

Jeanette J McCarthy

http://www.w3.org/2001/XMLSchema#string

Kathleen A Welsh-Bohmer

http://www.w3.org/2001/XMLSchema#string

Laura Saucier

http://www.w3.org/2001/XMLSchema#string

Ornit Chiba-Falek

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein in Lewy bodies

Haploview: analysis and visualization of LD and haplotype maps

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Multiple regions of alpha-synuclein are associated with Parkinson's disease.

P2888

s10048-010-0263-4

P304

59-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10048-010-0263-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47662060

http://www.w3.org/2001/XMLSchema#string

P698

21046180

http://www.w3.org/2001/XMLSchema#string

P932

3030669

http://www.w3.org/2001/XMLSchema#string